Chakraborty, A. ; Giraldo-Arias, J. ; Merl-Pham, J. ; Dick, E. ; Mastalerz, M. ; Zöller, M. ; Marchi, H. ; Le Gleut, R. ; Hatz, R.* ; Behr, J.* ; Hilgendorff, A. ; Hauck, S.M. ; Staab-Weijnitz, C.A.
     
 
    
        
Cholesterol regulates airway epithelial cell differentiation by inhibiting p53 nuclear translocation.
    
    
        
    
    
        
        Int. J. Mol. Sci. 26, 8324 - 8324 (2025)
    
    
    
		
		
			
				Cholesterol is an essential plasma membrane component, and altered cholesterol metabolism has been linked to cholesterol accumulation in the airways of COPD and cystic fibrosis patients. However, its role in airway epithelial differentiation is not well understood. Tandem mass spectrometry-based proteomic analysis of differentiating primary human bronchial epithelial cells (phBECs) revealed an overall inhibition of the cholesterol biosynthesis pathway. We hypothesized that excess cholesterol impairs the differentiation of phBECs into a fully functional bronchial epithelium. PhBECs were differentiated in the presence of 80 µM cholesterol for 21 days, the main airway cell type populations monitored using qRT-PCR and immunofluorescent stainings, and epithelial barrier integrity was analyzed via transepithelial electrical resistance measurements. Chronic cholesterol exposure led to a significant increase in CC10+ secretory cells at the expense of ciliated cells. Pathway enrichment analysis suggested the tumor protein p53 as a master regulator of genes during normal differentiation of phBECs. Chronic cholesterol exposure drastically impaired the nuclear translocation of p53. Our findings suggest that this inhibition underlies the cholesterol-induced expansion of CC10+ secretory cell populations at the expense of ciliated cells. In conclusion, we identify cholesterol as an important regulator of normal bronchial epithelial cell differentiation through inhibition of p53 nuclear translocation.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Ingenuity Pathway Analysis ; Cholesterol ; P53 ; Primary Human Bronchial Epithelial Cells; Label-free; Proteome; Notch; Homeostasis; Models; Blood
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2025
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2025
    
 
    
    
        ISSN (print) / ISBN
        1661-6596
    
 
    
        e-ISSN
        1422-0067
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 26,  
	    Heft: 17,  
	    Seiten: 8324 - 8324 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            MDPI
        
 
        
            Verlagsort
            Basel
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30202 - Environmental Health
30203 - Molecular Targets and Therapies
30505 - New Technologies for Biomedical Discoveries
    
 
    
        Forschungsfeld(er)
        Lung Research
Enabling and Novel Technologies
    
 
    
        PSP-Element(e)
        G-501600-001
G-505700-001
A-632200-001
G-552100-001
    
 
    
        Förderungen
        University of Colorado School of Medicine, Anschutz Medical Campus
Deutsches Zentrum für Lungenforschung
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2025-10-15